Assessment of pregestational insulin resistance as a risk factor of preeclampsia

Enrique Valdés1, Alvaro Sepúlveda-Martínez, Bárbara Manukián

  • 1Fetal Medicine Unit, University of Chile Hospital, Santiago de Chile, Chile.

Insights

Pregestational insulin resistance (PIR) is associated with preeclampsia (PE), but other factors like chronic hypertension and advanced maternal age are stronger predictors of PE development.

Area of Science:

  • Reproductive Medicine
  • Endocrinology
  • Maternal-Fetal Medicine

Background:

  • Pregestational insulin resistance (PIR) is a metabolic condition affecting women before pregnancy.
  • Preeclampsia (PE) is a serious pregnancy complication characterized by high blood pressure.
  • The relationship between PIR and PE risk requires further clarification.

Purpose of the Study:

  • To evaluate pregestational insulin resistance (PIR) as an independent risk factor for preeclampsia (PE).

Main Methods:

  • A nested case-control study was conducted.
  • Patients with PIR were compared to a randomly selected control group.
  • Clinical and hemodynamic data were analyzed using multiple logistic regression.

Main Results:

  • Women with PIR were older, had higher BMI, and higher rates of chronic hypertension and hypothyroidism.
  • PIR was associated with increased likelihood of developing PE and gestational diabetes mellitus.
  • Multivariate analysis identified maternal age, chronic hypertension, and uterine artery Doppler findings as significant PE predictors, not PIR.

Conclusions:

  • While PIR shows a correlation with PE, it may not be an independent predictor.
  • Established risk factors such as chronic hypertension, advanced maternal age, and higher BMI appear to be more dominant in predicting PE.
Abstract

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.9K
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
17
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
28
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated...
17
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and...
24